As the elevated EGFR, PI3K/Akt, and NF-kB activation is considered for the possible causes of developing chemoresistance/docetaxel resistance in cancer cells so USP8 silencing might also be a thinkable way to overcome docetaxel resistance for PCa. The gene discussed is NFKB1; the disease is posterior cortical atrophy.